1 Min Read
FRANKFURT, May 30 (Reuters) - Bayer AG : * Says receives EU approval for nexavar (sorafenib) for the treatm ent of
differentiated thyroid cancer
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.